Zagreb, Croatia

Jasna Dogan

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Zagreb, HR (2012 - 2020)
  • Petrinja, HR (2020 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Jasna Dogan: Innovator in Pharmaceutical Chemistry

Introduction

Jasna Dogan is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. Her work focuses on the development of solid-state forms of various pharmaceutical compounds, which are crucial for enhancing drug efficacy and stability.

Latest Patents

Among her latest patents are the solid-state forms of n-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4H-chromene-2-carboxamide and its mesylate salt. This patent relates to the solid-state forms of Encequidar (previously referred to as HM-30181A) base, Encequidar (HM-30181A) mesylate, and co-crystals of Encequidar (HM-30181A) mesylate, along with processes for their preparation and pharmaceutical compositions. Additionally, she has developed solid-state forms of Rucaparib and its salts, which are also detailed in her patents.

Career Highlights

Jasna has worked with notable companies in the pharmaceutical industry, including Assia Chemical Industries Ltd. and Pliva Hrvatska d.o.o. Her experience in these organizations has allowed her to refine her expertise in drug formulation and development.

Collaborations

Throughout her career, Jasna has collaborated with talented individuals such as Tomislav Biljan and Sara Morasi Pipercic. These partnerships have contributed to her innovative work in the field.

Conclusion

Jasna Dogan is a distinguished inventor whose contributions to pharmaceutical chemistry have led to the development of important drug formulations. Her patents reflect her commitment to advancing the field and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…